+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Enterprise Tech Ecosystem Series - Johnson & Johnson

Enterprise Tech Ecosystem Series - Johnson & Johnson


Johnson & Johnson (J&J) provides pharmaceuticals in the immunology, cancer, neuroscience, infectious, cardiovascular and metabolic disease areas through its subsidiary ‘Janssen Pharmaceutica’.


The report provides information and insights into Johnson & Johnson's including -
  • Insights of its digital transformation strategies
  • Details of various partnerships, network map, in-house launches, and other industry innovation programs
  • Detailed overview of Johnson & Johnson's technology centers and innovation programs and financial highlights.

Reasons to buy
  • Gain insights into Johnson & Johnson's technology innovations.
  • Gain insights into its Digital Transformation Strategy.
  • Gain insights into various product launches, partnership strategies of Johnson & Johnson.
  • Gain insights into various disruptive technologies and tech initiatives of the Company.

Table of Contents

  • Overview
  • Digital Transformation Strategy
  • Technology Centers and Innovation Programs
  • Technology Focus
  • Technology Initiatives
  • Johnson & Johnson Development Corp. (JJDC) - A Venture Capital Arm
  • JJDC Investments
  • Acquisitions
  • Partner, Investment, and Acquisition Network Map
  • ICT Budget & Contracts
  • Key Executives

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • SAP
  • Inkbit
  • HP
  • Capgemini
  • Carbon
  • IBM
  • Iktos
  • Organovo
  • medopad
  • AWS